dalteparin has been researched along with betadex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbruscato, TJ; Ahsan, F; Hussain, A; Paulson, J; Yang, T | 1 |
| Ahsan, F; Bai, S; Mustafa, F; Yang, T | 1 |
2 other study(ies) available for dalteparin and betadex
| Article | Year |
|---|---|
Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies.
Topics: Administration, Intranasal; Animals; Antithrombin III; beta-Cyclodextrins; Biological Availability; Biological Transport; Cell Extracts; Cells, Cultured; Dalteparin; Electric Conductivity; Enoxaparin; Heparin, Low-Molecular-Weight; Humans; Male; Mannitol; Membrane Proteins; Nasal Mucosa; Phosphoproteins; Rats; Rats, Sprague-Dawley; Zonula Occludens-1 Protein | 2004 |
Pulmonary delivery of low molecular weight heparins.
Topics: Animals; Anticoagulants; beta-Cyclodextrins; Biological Transport, Active; Bronchi; Cell Line; Chemistry, Pharmaceutical; Dalteparin; Dose-Response Relationship, Drug; Drug Delivery Systems; Electric Conductivity; Enoxaparin; Epithelial Cells; Factor Xa; Heparin, Low-Molecular-Weight; Humans; Lung; Male; Maltose; Rats; Rats, Sprague-Dawley; United States | 2004 |